Compare International Business Machines Corp (IBM) vs Revvity Inc (RVTY) Price & Performance

IBM's stock trades at $226.61, up 2.77% today, as recent news of self-hosted deployment for its Bob AI platform and positive sentiment from Accenture's earnings boost investor confidence. The technical picture is bearish with RSI at 71.56 suggesting overbought conditions, while fundamentals show strong revenue growth to $67.54B in 2025 and a net income margin of 15.52%. The company faces cyclical mainframe challenges but maintains a robust $5.5B generative AI consulting pipeline.

IBM presents a mixed outlook with solid profitability and AI growth offset by bearish technical signals and high debt levels. The consensus price target of $255.50 implies 12.8% upside, but investors must weigh competitive pressures in cloud and consulting against its hybrid-cloud strategy. Near-term performance hinges on Q3 2026 earnings due soon.

RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.

The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.